Xenon Pharmaceuticals Inc (XENE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 142,712 | 148,643 | 57,242 | 175,688 | 45,009 |
| Marketable Securities | 484,193 | 489,439 | 534,845 | 376,086 | 131,988 |
| Receivables | 1,469 | 874 | 986 | 2,765 | 1,822 |
| TOTAL | $635,264 | $644,962 | $600,298 | $559,020 | $181,783 |
| Non-Current Assets | |||||
| PPE Net | 10,278 | 9,653 | 6,500 | 4,466 | 3,554 |
| Investments And Advances | 127,496 | 292,792 | 128,682 | 0 | 0 |
| Other Non-Current Assets | 25,101 | 17,391 | 18,666 | 8,521 | 3,849 |
| TOTAL | $162,875 | $319,836 | $153,848 | $12,987 | $7,403 |
| Total Assets | $798,139 | $964,798 | $754,146 | $572,007 | $189,186 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 34,221 | 25,974 | 22,214 | 13,717 | 10,874 |
| TOTAL | $35,590 | $27,273 | $22,702 | $14,322 | $14,781 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | N/A | N/A | 3,642 |
| Other Non-Current Liabilities | 7,646 | 9,604 | 9,947 | 7,652 | 3,050 |
| TOTAL | $7,646 | $9,604 | $9,947 | $7,652 | $3,050 |
| Total Liabilities | $43,236 | $36,877 | $32,649 | $21,974 | $17,831 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 76,543 | 75,432 | 63,038 | 51,921 | 35,809 |
| Common Shares | 1,456,836 | 1,436,374 | 1,065,136 | 783,170 | 397,748 |
| Retained earnings | -899,470 | -665,140 | -482,747 | -357,374 | -278,492 |
| Other shareholders' equity | -1,612 | -77 | -3,000 | -990 | -990 |
| TOTAL | $754,903 | $927,921 | $721,497 | $550,033 | $171,355 |
| Total Liabilities And Equity | $798,139 | $964,798 | $754,146 | $572,007 | $189,186 |